101 related articles for article (PubMed ID: 25449474)
1. Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.
Xu H; Xie X; Wang B; Chen Y; Meng T; Ma S; Wang F
Int J Cardiol; 2014 Dec; 177(2):654-7. PubMed ID: 25449474
[No Abstract] [Full Text] [Related]
2. Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
Scott SA; Lubitz SA
Pharmacogenomics; 2014 Apr; 15(6):719-22. PubMed ID: 24897277
[TBL] [Abstract][Full Text] [Related]
3. [Impact of pharmacogenetic testing on the risk of bleedings and excessive hypocoagulation episodes in the use of warfarin: the first meta-analysis of Russian prospective studies].
Sychev DA; Ivashchenko DV; Rusin IV
Ter Arkh; 2014; 86(4):64-71. PubMed ID: 24864470
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin.
Kangelaris KN; Bent S; Nussbaum RL; Garcia DA; Tice JA
J Gen Intern Med; 2009 May; 24(5):656-64. PubMed ID: 19306050
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics-based warfarin dosing algorithm decreases time to stable anticoagulation and the risk of major hemorrhage: an updated meta-analysis of randomized controlled trials.
Wang ZQ; Zhang R; Zhang PP; Liu XH; Sun J; Wang J; Feng XF; Lu QF; Li YG
J Cardiovasc Pharmacol; 2015 Apr; 65(4):364-70. PubMed ID: 25551322
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of pharmacogenetics-guided dosing of warfarin: a systematic review and meta-analysis.
Tang Q; Zou H; Guo C; Liu Z
Int J Cardiol; 2014 Aug; 175(3):587-91. PubMed ID: 25005340
[No Abstract] [Full Text] [Related]
7. Pharmacogenomics and warfarin therapy.
Ndegwa S
Issues Emerg Health Technol; 2007 Oct; (104):1-8. PubMed ID: 17912794
[TBL] [Abstract][Full Text] [Related]
8. Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.
Yang T; Zhou Y; Chen C; Lu M; Ma L; Cui Y
J Clin Pharm Ther; 2019 Apr; 44(2):197-208. PubMed ID: 30593674
[TBL] [Abstract][Full Text] [Related]
9. Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.
Tang HL; Shi WL; Li XG; Zhang T; Zhai SD; Xie HG
Pharmacogenomics J; 2015 Dec; 15(6):496-504. PubMed ID: 25869011
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials.
Li X; Yang J; Wang X; Xu Q; Zhang Y; Yin T
Thromb Res; 2015 Apr; 135(4):621-9. PubMed ID: 25628141
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
Leey JA; McCabe S; Koch JA; Miles TP
Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
[TBL] [Abstract][Full Text] [Related]
12. International warfarin genotype-guided dosing algorithms in the Turkish population and their preventive effects on major and life-threatening hemorrhagic events.
Karaca S; Bozkurt NC; Cesuroglu T; Karaca M; Bozkurt M; Eskioglu E; Polimanti R
Pharmacogenomics; 2015; 16(10):1109-18. PubMed ID: 26216670
[TBL] [Abstract][Full Text] [Related]
13. Hematology consult: high-sensitivity warfarin genotype.
Schwer C; Lamana S; Dasanu CA
Conn Med; 2013; 77(10):581-5. PubMed ID: 24367840
[TBL] [Abstract][Full Text] [Related]
14. Genetic testing for warfarin therapy initiation.
Hynicka LM; Cahoon WD; Bukaveckas BL
Ann Pharmacother; 2008 Sep; 42(9):1298-303. PubMed ID: 18682545
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of pharmacogenomics guided warfarin dosing.
Mahajan P; Meyer KS; Wall GC; Price HJ
Int J Clin Pharm; 2011 Feb; 33(1):10-9. PubMed ID: 21365388
[TBL] [Abstract][Full Text] [Related]
16. Genetic warfarin dosing: tables versus algorithms.
Finkelman BS; Gage BF; Johnson JA; Brensinger CM; Kimmel SE
J Am Coll Cardiol; 2011 Feb; 57(5):612-8. PubMed ID: 21272753
[TBL] [Abstract][Full Text] [Related]
17. Warfarin: an old drug but still interesting.
Johnson JA
Pharmacotherapy; 2008 Sep; 28(9):1081-3. PubMed ID: 18752378
[No Abstract] [Full Text] [Related]
18. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications.
Aithal GP; Day CP; Kesteven PJ; Daly AK
Lancet; 1999 Feb; 353(9154):717-9. PubMed ID: 10073515
[TBL] [Abstract][Full Text] [Related]
19. A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy.
Avery PJ; Jorgensen A; Hamberg AK; Wadelius M; Pirmohamed M; Kamali F;
Clin Pharmacol Ther; 2011 Nov; 90(5):701-6. PubMed ID: 22012312
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials.
Wang X; Tang B; Zhou M; Liu L; Feng X; Wang X; Qiu K
Thromb Res; 2022 Feb; 210():42-52. PubMed ID: 34999431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]